Dr. Bindiya G. Patel, MD

Dr. Patel practices at Northwestern Catherine Gratz Griffin Lake Forest Hospital in Lake Forest, Illinois.

Dr. Patel's NPI, 1184087173, was assigned on March 29, 2016. Dr. Patel holds Illinois license 036165574.

Dr. Patel's primary practice is Northwestern Catherine Gratz Griffin Lake Forest Hospital, at 1000 N Westmoreland Rd, Lake Forest, IL 60045 in Lake County. The practice phone is (847) 234-5600.

Dr. Patel's primary practice is Northwestern Catherine Gratz Griffin Lake Forest Hospital in Lake Forest, Illinois. Dr. Patel is also affiliated with Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Patel to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patel practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Patel's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Patel's licenses on file in 2 states: Illinois and Missouri.

CMS data shows 1,324 Medicare services from Dr. Patel across 8 procedure codes in 2024, for 207 Medicare patients. Medicare paid $88,470 for them.

CMS counts 207 Medicare patients who saw Dr. Patel in 2024. The largest group is 75 to 84, with 93 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Patel's median patient age at 72, with 42% women.

In 2024, Dr. Patel wrote 285 Medicare Part D claims for 62 patients. 67% of them were for generic drugs. CMS names the drug for 156 of them, across 6 drugs with 11 or more claims each, at $77,977 in total drug cost. In 2019, CMS named 248 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Patel for performance year 2024, reported through an alternative payment model (APM). Dr. Patel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Patel as offering telehealth.

Dmand AI links 17 papers to Dr. Patel, published from 2011 to 2025. 2012 was the busiest year, with 2. The most frequent topics are Disease Models, Animal, Mice, Inbred C57BL and Heart Failure. Dr. Patel has published most often in Circ Heart Fail. Dr. Patel's most frequent co-authors are Sumanth Damodar Prabhu, MD, Tariq Hamid, MBBS and Samuel Calvert Dudley, MD, PhD.

CMS Open Payments shows 2 general payments to Dr. Patel from 2 drug and device companies from 2020 to 2022. Education make up the largest share, 100% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $100.